Advertisement
Screener

Vera Therapeutics, Inc. (VERA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Vera Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Vera Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $241.10M went out.
  • Fiscal year ended 2025-12-31: from investing, $194.29M came in.
  • Fiscal year ended 2025-12-31: from financing, $308.90M came in.
  • Fiscal year ended 2025-12-31: change in cash, $262.08M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2025-12-31-$241.10M$194.29M$0.00$308.90M*$262.08M
2024-12-31-$134.68M-$425.03M-$13.00K$606.69M*$46.97M
2023-12-31-$92.18M-$39.43M$0.00$133.54M*$1.93M
2022-12-31-$67.60M-$70.55M$2.00M$99.93M*-$36.22M
2021-12-31-$23.71M-$4.20M$0.00$53.88M*$25.97M
2020-12-31-$34.81M-$42.00K$230.00K$85.06M*$50.44M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2026-06-30-$100.25M*$32.86M*$1.92M*
2026-03-31-$106.50M-$137.82M$3.94M*-$240.37M
2025-12-31-$69.99M*$80.66M*$0.00*$286.28M*
2025-09-30-$61.91M*$69.76M*$797.00K*
2025-06-30-$54.80M*$28.54M*$20.29M*
2025-03-31-$54.41M$15.32M$1.53M*-$37.56M
2024-12-31-$39.18M*-$221.38M*$0.00*$325.95M*
2024-09-30-$36.88M*$38.32M*$739.00K*
2024-06-30-$24.78M*-$22.68M*$3.44M*
2024-03-31-$33.83M-$219.29M$276.54M*$23.42M
2023-12-31-$25.14M*$18.56M*$0.00*$24.83M*
2023-09-30-$22.97M*$16.23M*
2023-06-30-$17.77M*-$86.45M*
2023-03-31-$26.29M$12.23M$107.98M*$93.93M
2022-12-31-$21.16M*$13.44M*$20.71M*
2022-09-30-$18.42M*-$2.44M*$908.00K*
2022-06-30-$19.03M*-$42.09M*
2022-03-31-$8.98M-$39.45M$86.13M-$5.86M*$31.83M
2021-12-31-$6.44M*-$5.00M*-$51.18M*$56.10M*
2021-09-30-$5.48M*$0.00*$0.00*
2021-06-30-$7.67M*$796.00K*$51.18M*-$2.19M*
2021-03-31-$4.12M$0.00$0.00-$4.15M
2020-12-31-$27.38M*$57.00K*$207.00K*$79.59M*
2020-09-30-$2.45M*$0.00*-$61.00K*
2020-06-30-$2.67M*-$47.00K*$69.00K*$547.00K*
2020-03-31-$2.31M-$52.00K$15.00K$4.95M*$2.61M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
uniQure N.V. (QURE)$2.416B-4.93
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34